Stereotactic body radiotherapy for low-risk prostate cancer: Five-year outcomes

被引：0
|
作者：
Freeman, D.
King, C. R.
机构：
[1] Naples Radiat Oncol PA, Naples, FL USA
[2] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles Sch Med, Los Angeles, CA 90024 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.94
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
94
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Anwar, Mekhail
    Weinberg, Vivian V.
    Seymour, Zachary
    Hsu, I. Joe
    Roach, Mack, III
    Gottschalk, Alex R.
    [J]. RADIATION ONCOLOGY, 2016, 11
  • [32] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Mekhail Anwar
    Vivian Weinberg
    Zachary Seymour
    I. Joe Hsu
    Mack Roach
    Alex R. Gottschalk
    [J]. Radiation Oncology, 11
  • [33] Stereotactic body radiotherapy for prostate cancer: treatment approaches and clinical outcomes
    Miralbell, Raymond
    [J]. JOURNAL OF RADIOSURGERY AND SBRT, 2011, 1 (02): : 147 - 154
  • [34] Stereotactic ablative radiotherapy for low to intermediate risk prostate cancer
    Sadozye, A.
    Dodds, D.
    MacLeod, N.
    Lamb, C.
    Smith, S.
    Foster, J.
    Devlin, L.
    Dufton, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S679 - S680
  • [35] The 1989 patterns of care study for prostate cancer: Five-year outcomes
    Chuba, PJ
    Moughan, J
    Forman, JD
    Owen, J
    Hanks, G
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (02): : 325 - 334
  • [36] Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial
    Bowden, Patrick
    See, Andrew W.
    Frydenberg, Mark
    Haxhimolla, Hodo
    Costello, Anthony J.
    Moon, Daniel
    Ruljancich, Paul
    Grummet, Jeremy
    Crosthwaite, Alan
    Pranavan, Ganes
    Peters, Justin S.
    So, Kevin
    Gwini, Stella M.
    McKenzie, Dean P.
    Nolan, Skye
    Smyth, Lloyd M. L.
    Everitt, Craig
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (01) : 161 - 168
  • [37] Low-risk Prostate Cancer: Identification, Management, and Outcomes
    Moschini, Marco
    Carroll, Peter R.
    Eggener, Scott E.
    Epstein, Jonathan I.
    Graefen, Markus
    Montironi, Rodolfo
    Parker, Christopher
    [J]. EUROPEAN UROLOGY, 2017, 72 (02) : 238 - 249
  • [38] Percutaneous radiotherapy for low-risk prostate cancer: options for 2007
    Bottke, Dirk
    Wiegel, Thomas
    [J]. WORLD JOURNAL OF UROLOGY, 2007, 25 (01) : 53 - 57
  • [39] Percutaneous radiotherapy for low-risk prostate cancer: options for 2007
    Dirk Bottke
    Thomas Wiegel
    [J]. World Journal of Urology, 2007, 25 : 53 - 57
  • [40] A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma
    Sergiu Scobioala
    Christopher Kittel
    Khaled Elsayad
    Kai Kroeger
    Michael Oertel
    Laith Samhouri
    Uwe Haverkamp
    Hans Theodor Eich
    [J]. Radiation Oncology, 14
12345